---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017053"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T15:13:40.538837+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical added to Russell Microcap Index effective June 30, 2025

## Summary
- Added to the Russell Microcap Index as of market open on June 30, 2025, with automatic inclusion in growth and value style indexes.
- CEO Harel Gadot cited strong execution, ongoing FDA 510(k) submission for LIBERTY, and anticipated Q3 commercial launch.
- Membership is based on market-cap rankings; Russell indexes serve as benchmarks for about $10.6 trillion in assets (June 2024).
- Microbot Medical (MBOT) is a pre-commercial endovascular robotics developer; LIBERTY is pending FDA 510(k) clearance.

## SEC filing metadata
- accession: 0001641172-25-017053
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225017053/0001641172-25-017053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225017053/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017053
- JSON: https://secwatch.observer/filing/0001641172-25-017053.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.